CVS Health revenue and financials

CVS · NYSE · USD

$86.43Change from previous close: −0.67%Absolute change: −$0.58

Close · October 6, 2026

In the fiscal year ended December 2025, CVS Health reported revenue of $402.07B (+7.85% year over year). Net income was $1.77B, a net margin of 0.4%.

Annual revenue · 2025: $402.07B
  1. $177.55B2016
  2. $184.79B2017
  3. $194.58B2018
  4. $256.78B2019
  5. $268.71B2020
  6. $292.11B2021
  7. $322.47B2022
  8. $357.78B2023
  9. $372.81B2024
  10. $402.07B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+7.85%
2025 vs 2024
Net income growth
−61.68%
2025 vs 2024
Net margin
0.4%
2024: 1.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating cash flow6,3454,2493,3907961,8974,5561,860-7453,0894,903-2,6362,716
Depreciation and amortization1,1261,1151,1471,1341,1711,1541,1471,1611,1511,1381,1341,127
Capital expenditure-691-849-784-698-607-743-768-670-638-705-911-545
Investing cash flow-1,884-874-1,998-2,087-1,024-762-547-3,347-1,625-2,094-1,242-771
Financing cash flow-2,693-2,318-2,032-1,382806-2,332431-1,5881,249-1,227-972-2,697
Dividends paid-878-847-845-846-866-840-838-837-858-840-779-779
Share repurchases-145-9.0-13.0-20.0-114-11.0-4.0-4.0-142-3,058-5.0-4.0
Debt issued——0.03,048921—4,2736002,4402,519200-1,000
Debt repaid-1,769-1,518-1,267-3,719840-1,602-3,067-1,469-219-18.0-432-947
Net change in cash1,7681,057-640-2,6731,6791,4621,744-5,6802,7131,582-4,850-752
Free cash flow5,6543,4002,60698.01,2903,8131,092-1,4152,4514,198-3,5472,171
Levered free cash flow5,3812,758229-6062,5473,4861,276-1,7483,2513,864-3,5851,844